Cargando…
Mind the Gap: Platelet Inhibition in Low‐Risk Acute Coronary Syndrome Undergoing Percutaneous Revascularization
Autores principales: | Sharma, Ravi K., Pinto, Duane S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912963/ https://www.ncbi.nlm.nih.gov/pubmed/31766972 http://dx.doi.org/10.1161/JAHA.119.014498 |
Ejemplares similares
-
Outcomes of Women and Men With Acute Coronary Syndrome Treated With and Without Percutaneous Coronary Revascularization
por: Udell, Jacob A., et al.
Publicado: (2017) -
Triglyceride-glucose index for predicting repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention
por: Guo, Xuantong, et al.
Publicado: (2023) -
Myocardial revascularization at extremes – surgical revascularization in acute coronary syndrome
por: Kacar, S, et al.
Publicado: (2013) -
A Study of Cardiac Autonomic Functions in Patients with Chronic Stable Angina Undergoing Percutaneous Coronary Revascularization
por: Alauddin, Waqas, et al.
Publicado: (2021) -
De-escalation of anti-platelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a narrative review
por: Han, Ya-Ling
Publicado: (2019)